Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lofarma is a research-driven pharmaceutical company specializing in the diagnosis and treatment of allergic diseases. The company is best known for developing and commercializing monomeric allergoid immunotherapy, marketed under the brand name LAIS, which allows for sublingual administration with high patient compliance. Lofarma's product portfolio includes a wide range of diagnostic tools, such as skin prick tests, and therapeutic solutions for respiratory and venom allergies. Headquartered in Milan, Italy, the company operates internationally with a significant presence in Germany through its subsidiary, Lofarma Deutschland, providing specialized allergology services and products to the European market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lofarma Deutschland.